Please login to the form below

Not currently logged in
Email:
Password:

drug recall

This page shows the latest drug recall news and features for those working in and with pharma, biotech and healthcare.

Sun Pharma recalls antidepressant in US

Sun Pharma recalls antidepressant in US

Withdraws more than 40, 000 bottles of venlafaxine hydrochloride. India-based Sun Pharmaceutical Industries is to recall more than 40, 000 bottles of an antidepressant after the drug was discovered to ... US regulator the FDA announced the recall of

Latest news

  • Pfizer recalls depression drug in US Pfizer recalls depression drug in US

    The company also warned of potential contraindications and drug-drug interactions that patients may have if they mistakenly take Tikosyn. ... Although voluntary, Pfizer said the recall is being conducted with the knowledge of the US FDA.

  • FDA suspends sale of Ariad’s cancer drug FDA suspends sale of Ariad’s cancer drug

    Iclusig linked to increased risk of blood clots. The US Food and Drug Administration (FDA) has asked Ariad to suspend sales of its leukaemia drug Iclusig as it continues to investigate ... Ariad was also forced to stop the EPIC trial of the drug in

  • Novo Nordisk recalls insulin Novo Nordisk recalls insulin

    Diabetes patients in Europe were warned to be on alert after Novo Nordisk announced a recall of several batches of its NovoMix insulin. ... We are working closely with national health authorities to ensure patient safety and minimise the disruption this

  • Communications rethink for Health Canada Communications rethink for Health Canada

    Committing to doing an additional assessment of the impact of a drug recall on Canadians, in addition to the health risk assessments currently done according to internationally recognised scientific standards. ... The review has provided timely and

  • Affymax in a tailspin after Omontys recall Affymax in a tailspin after Omontys recall

    Makes heavy job cuts in face of bankruptcy threat. Affymax is slashing three quarters of its workforce and could be facing bankruptcy in the wake of the recall last month of ... kidney disease drug Omontys, its only marketed product.

More from news
Approximately 4 fully matching, plus 14 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
bmore group

OUR PROMISE: BETTER HEALTH FROM TRIAL TO TREATMENT.We are a full service, independent network of specialist agencies under one roof....

Latest intelligence

Alzheimers incidence
A roadmap to the successful treatment of Alzheimer’s disease
Building on past research to learn more about the disease and how to treat it...
Article: Like, Like, Like: Harnessing the power of social media insights
...
Its Know Your Numbers week
Do you know yours?...

Infographics